Updates in the Treatment of Renal Cell Carcinoma: Highlights from IKCS and ESMO 2022

home / readout-360 / updates-in-the-treatment-of-renal-cell-carcinoma-highlights-from-ikcs-and-esmo-2022

A panel of experts review key data updates in renal cell carcinoma (RCC) from the International Kidney Cancer Association (IKCS) and European Society for Medical Oncology (ESMO) 2022 meetings and discuss how recent clinical trials are shaping the treatment of clear cell and non-clear cell RCC in clinical practice.